Therapeutic effect and molecular mechanism of Chinese medicine monomer on ulcerative colitis

Status

Recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000033889

Enrollment

Unknown

Registered

2020-06-15

Start date

2020-06-01

Completion date

Unknown

Last updated

2020-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ulcerative colitis

Interventions

normal group vs. UC group:Nil

Eligibility

Sex/Gender

Male

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. The initial population meeting the diagnostic criteria of western medicine for ulcerative colitis and the corresponding number of normal people undergoing colonoscopy. 2. People aged between 18 and 65 years.

Exclusion criteria

Exclusion criteria: 1. Patients treated for ulcerative colitis. 2. Patients who are at risk of perforation and massive bleeding and cannot be biopsied. 3. Pregnant patients.

Design outcomes

Primary

Measure	Time frame
signal pathway;Intestinal pathological changes;	—

Countries

China

Contacts

Public ContactYao HuiXiang

Department of Gastroenterology, Shanghai Jiaotong University Affiliated Sixth People's Hospital

yaohuixiang2016@sina.com+86 13917833198

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026